Target intelligence / Profile preview

Biogenesis of lysosomal organelles complex 3 subunit 2 (HPS4)

Target
HPS4
Molecular classification
Other (specifically: member of a multisubunit protein complex, not an enzyme, receptor, transporter, or ion channel)
01

Overview

Biogenesis of lysosomal organelles complex 3 subunit 2 (HPS4) is a protein that forms a stable heterodimeric complex with HPS1, known as the BLOC-3 complex[1][2]. This complex is involved in the trafficking and biogenesis of lysosome-related organelles, including melanosomes in pigment cells and platelet dense granules. BLOC-3 acts as a guanine nucleotide exchange factor (GEF) for the small GTPases RAB32 and RAB38 and is an effector of RAB9A, thereby regulating essential processes in vesicle trafficking and organelle function[1]. Mutations in HPS4 disrupt this complex and lead to Hermansky-Pudlak syndrome type 4, a rare autosomal recessive disorder characterized by albinism, bleeding diathesis, and, in some subtypes, fatal pulmonary fibrosis[1][2]. HPS4 itself is not classically considered a direct therapeutic drug target such as a receptor or enzyme, but pathogenic variants in HPS4 are clinically relevant for diagnosis and disease understanding in the context of lysosome-related organelle diseases[2].

Other names
BLOC-3 complex member HPS4KIAA1667LE (light-ear protein homolog)BLOC3S2Hermansky-Pudlak syndrome 4 protein
02

Biological functions

Organelle biogenesis (lysosome-related organelle formation)Vesicle traffickingRegulation of lysosome and endosome localizationRegulation of immune responses against intracellular pathogens
03

Disease associations

Hermansky-Pudlak syndrome (HPS), especially the subtype associated with pigment dilution and risk of pulmonary fibrosisOther lysosome-related organelle disorders

Beyond the preview

Go deeper on Biogenesis of lysosomal organelles complex 3 subunit 2 (HPS4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biogenesis of lysosomal organelles complex 3 subunit 2 (HPS4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call